ONC, CMS to Exercise Enforcement Discretion for Interoperability Requirements
Senate Passes Emergency Funding Package Aimed for Providers and Small Businesses
FDA Approves Ibrutinib in Combination with Rituximab for CLL or SLL
CMS Issues Guidance for Some Facilities to Re-Start Non-Essential Services
FDA Approves Pemigatinib for Certain Unresectable Advanced Cholangiocarcinomas
FDA Approves Tucatinib in Combination for Advanced HER2-Positive Breast Cancer
FDA Approves Eltrombopag 25-mg Powder for Suspension Package Size
Trastuzumab-dttb, Biosimilar of Herceptin, Launches on U.S. Market
CMS Issues Guidance on Payer COVID-19 Coverage
ASCO Launches COVID-19 Registry
HHS Starts Distribution of $30 Billion in Provider Relief Funds
CMS Adds New COVID-19 Workforce Flexibility Waivers
No Change to Open Payments Dispute Timeline, CMS Says
FDA Approves Braftovi in Combo with Cetuximab for mCRC with BRAF V600E Mutation
CMS Issues Updated Infection Control Guidance for Inpatient & Outpatient Care
HHS Announces Upcoming Funding to Provide $186 Million for COVID-19 Response
FDA Approves Durvalumab for Extensive-Stage Small Cell Lung Cancer
CMS Expands Accelerated & Advance Payment Program for Medicare Providers & Suppliers
President Trump Signs CARES Act
ASCO Announces Virtual Annual Meeting
FDA OCE Message to Oncology Providers & Patients on COVID-19
CMS FAQs on Medicare Provider Enrollment Relief in Response to COVID-19
CMS Announces Exceptions & Extensions for Quality Reporting Requirements
CMS Provides FAQs on Essential Health Benefits Coverage for COVID-19
CMS Posts Fact Sheet on Coverage for COVID-19 Tests
Report to the Nation Shows Overall Decline in Cancer Death Rates
CMS Issues Guidance to Help MA & Part D Plans Respond to COVID-19
FDA Approves Opdivo Plus Yervoy Combo For HCC Patients Previously Treated with Sorafenib
HHS Issues Final Interoperability and Patient Access Rule
USPSTF New Guideline Calls for HCV Screening for Adults Aged 18 to 79
